Previous close | 4.7000 |
Open | 4.7000 |
Bid | 3.8000 |
Ask | 4.2000 |
Strike | 20.00 |
Expiry date | 2025-01-17 |
Day's range | 4.7000 - 4.7000 |
Contract range | N/A |
Volume | |
Open interest | 43 |
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
The analysts might have been a bit too bullish on Prothena Corporation plc ( NASDAQ:PRTA ), given that the company fell...